UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 85

Sortiert nach

FMT for Severe C. difficile Infection: If at First You Do No Harm, the Second Time’s a Charm

Digestive diseases and sciences, 2021, Vol.66 (1), p.5-6

Grinspan, Ari

2021

Volltextzugriff (PDF)

Hospital-onset Clostridioides difficile infections during the COVID-19 pandemic

Infection control and hospital epidemiology, 2021-09, Vol.42 (9), p.1165-1166

2021

Volltextzugriff (PDF)

S3229 Does Fecal Microbiota Transplantation Affect the Comorbidities Associated With Type 2 Diabetes Mellitus?

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S1331-S1331

2021

Volltextzugriff (PDF)

The Gut Microbiome: A Primer for the Clinician

The American journal of gastroenterology, 2024-01, Vol.119 (1S), p.S2-S6

2024

Volltextzugriff (PDF)

Interactions Between Diet and the Intestinal Microbiota Alter Intestinal Permeability and Colitis Severity in Mice

Gastroenterology (New York, N.Y. 1943), 2018-03, Vol.154 (4), p.1037-1046.e2

2018

Volltextzugriff (PDF)

Epidemiology of community-acquired and recurrent Clostridioides difficile infection

Therapeutic Advances in Gastroenterology, 2021, Vol.14, p.175628482110162-17562848211016248

2021

Volltextzugriff (PDF)

Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients

Alimentary pharmacology & therapeutics, 2019-11, Vol.50 (10), p.1094-1099

2019

Volltextzugriff (PDF)

Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence

Digestive diseases and sciences, 2020-12, Vol.65 (12), p.3647-3651

2020

Volltextzugriff (PDF)

S1725 Lifestyle Medicine Interventions Successfully Reduce Typical Symptoms of GERD in a World Trade Center First Responder Cohort

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S1285-S1286

2023

Volltextzugriff (PDF)

Fecal Transplants by Colonoscopy and Capsules Are Cost-Effective Strategies for Treating Recurrent Clostridioides difficile Infection

Digestive diseases and sciences, 2020-04, Vol.65 (4), p.1125-1133

2020

Volltextzugriff (PDF)

Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile

Digestive diseases and sciences, 2022-03, Vol.67 (3), p.978-988

2022

Volltextzugriff (PDF)

Outcomes After Fecal Microbiota Transplantation in Combination With Bezlotoxumab for Inflammatory Bowel Disease and Recurrent Clostridioides difficile Infection

The American journal of gastroenterology, 2024-07, Vol.119 (7), p.1433-1436

2024

Volltextzugriff (PDF)

Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry

Gastroenterology (New York, N.Y. 1943), 2021-01, Vol.160 (1), p.183-192.e3

2021

Volltextzugriff (PDF)

Fecal Microbiota Transplantation for Ulcerative Colitis: Not Just Yet

Gastroenterology (New York, N.Y. 1943), 2015-07, Vol.149 (1), p.15-18

2015

Volltextzugriff (PDF)

Precise quantification of bacterial strains after fecal microbiota transplantation delineates long-term engraftment and explains outcomes

Nature microbiology, 2021-10, Vol.6 (10), p.1309

2021

Volltextzugriff (PDF)

Wearable Devices Are Well Accepted by Patients in the Study and Management of Inflammatory Bowel Disease: A Survey Study

Digestive diseases and sciences, 2021-06, Vol.66 (6), p.1836-1844

2021

Volltextzugriff (PDF)

S145 Week 24 Efficacy and Safety Data from PRISM3: A Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for the Prevention of Recurrent C. difficile Infection

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S63-S64

2021

Volltextzugriff (PDF)

S144 CP101 Engraftment Drives Efficacy: Results From a Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for Prevention of Recurrent C. difficile Infection

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S63-S63

2021

Volltextzugriff (PDF)

S131 CP101, an Investigational Orally Administered Microbiome Therapeutic, Increases Intestinal Microbiome Diversity and Prevents Recurrent C. difficile Infection: Results From a Randomized, Placebo-Controlled Trial

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S57-S57

2021

Volltextzugriff (PDF)

Fecal Microbiota Transplantation in Inflammatory Bowel Disease Patients With Clostridium difficile Infection

Gastroenterology & hepatology, 2019-09, Vol.15 (9), p.481-483

Grinspan, Ari

2019

Volltextzugriff (PDF)

Fecal Microbiota Transplant for Clostridioides Difficile Infection Is Safe and Efficacious in an Immunocompromised Cohort

Digestive diseases and sciences, 2022-10, Vol.67 (10), p.4866-4873

2022

Volltextzugriff (PDF)

Sa1855 - Multiple Fecal Microbiota Transplants for Clostridium Difficile Infections

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-420-S-420

2018

Volltextzugriff (PDF)

650 Neoadjuvant ezabenlimab or pembrolizumab in combination with an anti-SIRPα antibody in resectable colorectal cancer

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A741-A741

2023

Volltextzugriff (PDF)

Safety and Efficacy of Fecal Microbiota Transplantation for Clostridium Difficile in a Cohort of Patients with a Severe Infection And/or IBD: 1022

The American journal of gastroenterology, 2016-10, Vol.111, p.S446

2016

Volltextzugriff (PDF)

Microbiome predictors of dysbiosis and VRE decolonization in patients with recurrent C. difficile infections in a multi-center retrospective study

AIMS microbiology, 2019-01, Vol.5 (1), p.1-18

2019

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(82)
Buchkapitel
(3)

Sprache

Englisch
(85)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

FMT for Severe C. difficile Infection: If at First You Do No Harm, the Second Time’s a Charm

Hospital-onset Clostridioides difficile infections during the COVID-19 pandemic

S3229 Does Fecal Microbiota Transplantation Affect the Comorbidities Associated With Type 2 Diabetes Mellitus?

The Gut Microbiome: A Primer for the Clinician

Interactions Between Diet and the Intestinal Microbiota Alter Intestinal Permeability and Colitis Severity in Mice

Epidemiology of community-acquired and recurrent Clostridioides difficile infection

Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients

Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence

S1725 Lifestyle Medicine Interventions Successfully Reduce Typical Symptoms of GERD in a World Trade Center First Responder Cohort

Fecal Transplants by Colonoscopy and Capsules Are Cost-Effective Strategies for Treating Recurrent Clostridioides difficile Infection

Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile

Outcomes After Fecal Microbiota Transplantation in Combination With Bezlotoxumab for Inflammatory Bowel Disease and Recurrent Clostridioides difficile Infection

Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry

Fecal Microbiota Transplantation for Ulcerative Colitis: Not Just Yet

Precise quantification of bacterial strains after fecal microbiota transplantation delineates long-term engraftment and explains outcomes

Wearable Devices Are Well Accepted by Patients in the Study and Management of Inflammatory Bowel Disease: A Survey Study

S145 Week 24 Efficacy and Safety Data from PRISM3: A Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for the Prevention of Recurrent C. difficile Infection

S144 CP101 Engraftment Drives Efficacy: Results From a Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for Prevention of Recurrent C. difficile Infection

S131 CP101, an Investigational Orally Administered Microbiome Therapeutic, Increases Intestinal Microbiome Diversity and Prevents Recurrent C. difficile Infection: Results From a Randomized, Placebo-Controlled Trial

Fecal Microbiota Transplantation in Inflammatory Bowel Disease Patients With Clostridium difficile Infection

Fecal Microbiota Transplant for Clostridioides Difficile Infection Is Safe and Efficacious in an Immunocompromised Cohort

Sa1855 - Multiple Fecal Microbiota Transplants for Clostridium Difficile Infections

650 Neoadjuvant ezabenlimab or pembrolizumab in combination with an anti-SIRPα antibody in resectable colorectal cancer

Safety and Efficacy of Fecal Microbiota Transplantation for Clostridium Difficile in a Cohort of Patients with a Severe Infection And/or IBD: 1022

Microbiome predictors of dysbiosis and VRE decolonization in patients with recurrent C. difficile infections in a multi-center retrospective study

Suchergebnisse filtern